elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33387673-96CAAAAE-AE72-406A-9D26-D8D6473D9D96
Q33387673-96CAAAAE-AE72-406A-9D26-D8D6473D9D96
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33387673-96CAAAAE-AE72-406A-9D26-D8D6473D9D96
Phase I dose escalation study of gemcitabine plus irinotecan in advanced solid tumors.
P433
Q33387673-96CAAAAE-AE72-406A-9D26-D8D6473D9D96
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33387673-96CAAAAE-AE72-406A-9D26-D8D6473D9D96
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a2346bacea0c269fff2024fa9e03bac4827b35b1
P433
12
http://www.w3.org/2001/XMLSchema#string